Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Income from Continuing Operations (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Income from Continuing Operations for 2 consecutive years, with 32785000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 58.99% to 32785000.0 in Q4 2025 year-over-year; TTM through Oct 2025 was 123219000.0, a 86.33% decrease, with the full-year FY2025 number at 105552000.0, down 40.04% from a year prior.
  • Income from Continuing Operations was 32785000.0 for Q4 2025 at Kestra Medical Technologies, down from 25826000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3589000.0 in Q2 2024 to a low of 42849000.0 in Q2 2025.